Jump to content
  • 3rd European QA Conference 2019

    Europe's largest quality event in the industry, book your early bird place now.

    View Programme
  • Become a Member

    You can now apply for RQA membership online.

    Join Now
  • GCP Regulatory Inspections

    Next running 8th October.

    View Programme

News Archive

MHRA Pharmacovigilance Inspection Metrics

6th February 2019

The MHRA GPvP inspectorate recently published their latest inspection metrics for the period from April 2017 to March 2018.

Read More+

EMA - Change of Address

5th February 2019

The EMA London office will close on the 1st March 2019 and re-open on the 4th March in Amsterdam....

Read More+

EMA Relocation Updates

23rd January 2019

The European Medicines Agency (EMA) will physically relocate to the Netherlands in early March 2019. The Dutch authorities have already officially handed over the temporary building, the Spark building in Amsterdam Sloterdijk, to EMA’s Executive Director Guido Rasi on 9 January 2019 and EMA is now preparing for its physical move.

Read More+

MHRA Guidance in the event of a no-deal Brexit

3rd January 2019

MHRA Guidance on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal....

Read More+

MHRA Healthcare Inspector Applications

12th December 2018

The MHRA have recently introduced a new inspector role, the Healthcare Inspector, which is currently open for applications.

Read More+

Medical Devices FDA News

11th September 2018

Quality in 510(k) 'Quik' Review Programme Pilot The FDA has launched the Quality in 510(k) ('Quik') Review Programme pilot. The goal of this pilot is to simplify how manufacturers of certain moderate risk medical devices complete a premarket notification (510(k)) submission, and to evaluate whether use of the FDA’s free eSubmitter software will result in well-organised submissions that can be reviewed more efficiently.

Read More+

Brexit: EMA updates information for holders of centralised marketing authorisations

7th August 2018

According to the European Medicines Agency (EMA), marketing authorisation holders (MAHs), applicants and sponsors of centrally authorised medicines for human or veterinary use should consider how Brexit will impact their medicines and which changes need to be addressed before the UK leaves the EU. They also need to ensure that the necessary changes are made by that date.

Read More+

Brexit - UK Government update on implementation period

6th August 2018

The British Government has issued technical information on what the implementation period means for the life science sector. This includes details on how the EU’s new Clinical Trials Regulation (CTR) will be approached by the UK.

Read More+

MHRA have joined government hub

18th July 2018

From 18 June 2018 the Agency moved out of its Victoria location to a new, modern office in Canary Wharf. The relocation follows the establishment in 2016, announced by the Cabinet Office, of a new Government Hub for more than 5,000 civil and public servants in East London.

Read More+

EMA Guidance

20th June 2018

The European Medicines Agency (EMA) and the European Commission have updated their guidance to help pharmaceutical companies prepare for the United Kingdom’s (UK) withdrawal from the European Union (EU).

Read More+
« Previous | Page 1 of 3 | Next »